PittPharmacy graduate student, Tao Long, was selected to present two of his posters entitled “Assessment of Interdialytic Dosing Schedules in PK Studies for Non-renally Eliminated Drugs in Patients with End Stage Renal Disease (ESRD)” and “The Impact of Uremic Solutes on Transporters in Patients with End Stage Renal Disease (ESRD)” at the 2018 US Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) Science Day on February 2nd, in Silver Spring, Maryland. The two research projects were conducted during his ORISE summer fellowship at FDA in 2017.

The OCP Science Day is an office-wide event, which provides a forum for showcasing clinical pharmacology research within the office and provides an opportunity for professional development. This year’s event covered a broad array of topics, including Pharmacokinetic/pharmacodynamics (PK/PD) modeling and simulation, physiologically based pharmacokinetic (PBPK) models, drug-drug interaction (DDI), knowledge and database management, etc.

Long is a PhD candidate in the biochemical pharmacology track. Research Professor Jeffrey Yao, PhD, FACB is Long’s advisor.

Comments are closed.